Arterial function and cardiorenal damage.
作者信息
Ruilope Luis M
机构信息
Instituto de Investigación & Unidad de Hipertension, Hospital 12 de Octubre, Madrid, Spain.
出版信息
J Clin Hypertens (Greenwich). 2014 Jun;16(6):398. doi: 10.1111/jch.12318. Epub 2014 Apr 25.
Abstract
摘要
相似文献
1
Arterial function and cardiorenal damage.
J Clin Hypertens (Greenwich). 2014 Jun;16(6):398. doi: 10.1111/jch.12318. Epub 2014 Apr 25.
2
Aortic to brachial pulse pressure amplification as functional marker and predictor of renal function loss in chronic kidney disease.
J Clin Hypertens (Greenwich). 2014 Jun;16(6):401-5. doi: 10.1111/jch.12316. Epub 2014 Apr 25.
3
Ambulatory central blood pressure: a new opportunity for mechanistic and clinical cardiovascular research.
Hypertension. 2013 Jun;61(6):1148-9. doi: 10.1161/HYPERTENSIONAHA.113.01188. Epub 2013 Apr 29.
4
Aortic-Brachial Pulse Wave Velocity Ratio: A Blood Pressure-Independent Index of Vascular Aging.
Hypertension. 2017 Jan;69(1):96-101. doi: 10.1161/HYPERTENSIONAHA.116.08409. Epub 2016 Nov 7.
5
Comparsion of central aortic pressure to brachial artery pressure in hypertensive patients on drug treatment: An observational study.
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S208-S212. doi: 10.1016/j.ihj.2018.10.418. Epub 2018 Nov 14.
6
Blood pressure goals and arterial stiffness in chronic kidney disease.
J Clin Hypertens (Greenwich). 2009 Apr;11(4):201-6. doi: 10.1111/j.1751-7176.2009.00096.x.
7
Influence of ventricular ejection on the relationship between central aortic and brachial pressure pulse in man.
Cardiovasc Res. 1970 Jul;4(3):291-300. doi: 10.1093/cvr/4.3.291.
8
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension.
Hypertens Res. 2011 Apr;34(4):445-7. doi: 10.1038/hr.2010.276. Epub 2011 Jan 13.
9
Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD.
Am J Kidney Dis. 2006 Dec;48(6):926-34. doi: 10.1053/j.ajkd.2006.08.008.
10
Vascular endothelial function and blood pressure regulation in afferent autonomic failure.
Am J Hypertens. 2015 Feb;28(2):166-72. doi: 10.1093/ajh/hpu144. Epub 2014 Aug 15.
本文引用的文献
1
Aortic to brachial pulse pressure amplification as functional marker and predictor of renal function loss in chronic kidney disease.
J Clin Hypertens (Greenwich). 2014 Jun;16(6):401-5. doi: 10.1111/jch.12316. Epub 2014 Apr 25.
2
Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.
Diabetes Care. 2014;37(1):226-34. doi: 10.2337/dc13-0985. Epub 2013 Aug 12.
3
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
4
Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study.
Clin J Am Soc Nephrol. 2013 Mar;8(3):424-33. doi: 10.2215/CJN.07900812. Epub 2012 Dec 27.
5
Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii81-8. doi: 10.1093/ndt/gfs270. Epub 2012 Jun 25.
6
Should the blood pressure or the blood vessel be the target of therapy?
Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1397-401. doi: 10.1586/erc.11.115.
7
Renal function and target organ damage in hypertension.
Eur Heart J. 2011 Jul;32(13):1599-604. doi: 10.1093/eurheartj/ehr003. Epub 2011 Mar 28.
8
Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?
Hypertension. 2010 Feb;55(2):415-21. doi: 10.1161/HYPERTENSIONAHA.109.135087. Epub 2009 Dec 14.
Zotero 插件